Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Artery Research

Open Access 06-03-2024 | Hypertension | Commentary

Alternative Interpretations on the Case for Non-invasive Central Aortic Pressure Monitoring

Authors: James D. Cameron, James E. Sharman

Published in: Artery Research

Login to get access

Excerpt

The derivation and application of estimates of central blood pressure continues to generate discussion and debate with published commentaries expressing a range of views regarding the use of central blood pressure (BP) in the management of hypertension. The fundamental point of issue should, however, not be related to device specifics but, assuming a reliable estimate is available, be on the clinical place of central BP estimation and of appropriate use in management of cardiovascular disease, is it under- or over-utilised? …
Literature
1.
Cameron JD. Comparison of noninvasive devices for assessing central blood pressure parameters: what to compare, when and why. J Hypertens. 2013;31:27–31.CrossRefPubMed
2.
Sharman JE. Central pressure should be used in clinical practice. Artery Res. 2015;9:1–7.CrossRef
3.
4.
Kesten S, Qasem A, Avolio A. Viewpoint: the case for non-invasive central aortic pressure monitoring in the management of hypertension. Artery Res. 2022;28:128–39.
5.
Huang QF, Aparicio LS, Thijs L, et al. Cardiovascular end points and mortality are not closer associated with central than peripheral pulsatile blood pressure components. Hypertension. 2020;76:350–8.CrossRefPubMed
6.
Lamarche F, Agharazii M, Madore F, Goupil R. Prediction of cardiovascular events by type I central systolic blood pressure: a prospective study. Hypertension. 2021;77(2):319–27.
7.
Cheng YB, Thijs L, Aparicio LS, et al. Risk stratification by cross-classification of central and brachial systolic blood pressure. Hypertension. 2022;79(5):1101–11.
8.
Bui TV, Picone DS, Schultz MG, et al. Comparison between cuff-based and invasive systolic blood pressure amplification. J Hypertens. 2022;40:2037–44.CrossRefPubMed
9.
Picone DS, Schultz MG, Otahal P, et al. Accuracy of cuff-measured blood pressure: systematic reviews and meta-analyses. J Am Coll Cardiol. 2017;70:572–86.CrossRefPubMed
10.
Sharman JE, Tan I, Stergiou GS, et al. Automated “Oscillometric” blood pressure measuring devices: how they work and what they measure. J Hum Hypertens. 2023;37:93–100.CrossRefPubMed
11.
Narayan O, Casan J, Szarski M, et al. Estimation of central aortic blood pressure: a systematic meta-analysis of available techniques. J Hypertens. 2014;32:1727–40.CrossRefPubMed
12.
Papaioannou TG, Karageorgopoulou TD, Sergentanis TN, et al. Accuracy of commercial devices and methods for noninvasive estimation of aortic systolic blood pressure a systematic review and meta-analysis of invasive validation studies. J Hypertens. 2016;34:1237–48.CrossRefPubMed
13.
Laugesen E, Knudsen ST, Hansen KW, et al. Invasive aortic pulse pressure is not superior to cuff pulse pressure in cardiovascular risk prediction. J Hypertens. 2021;39:607–13.CrossRefPubMed
14.
Lurbe E, Redon J. Isolated systolic hypertension in young people is not spurious and should be treated. Hypertension. 2016;68:276–80.CrossRefPubMed
15.
McEniery CM, Yasmin, Wallace S, et al. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension. 2005;46:221–6.CrossRefPubMed
16.
Sharman JE, Marwick TH, Gilroy D, et al. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the bp guide study. Hypertension. 2013;62:1138–45.CrossRefPubMed
17.
Leung MCH, Meredith IT, Cameron JD. Aortic stiffness affects the coronary blood flow response to percutaneous coronary intervention. Am J Physiol-Heart Circulat Physiol. 2006;290:H624–30.CrossRef
18.
Williams B. Differential impact of blood pressure-lowering drugs on central arterial pressure influences clinical outcomes—principal results of the conduit artery function evaluation (Cafe) study in ascot. Circulation. 2005;112:3362.
Metadata
Title
Alternative Interpretations on the Case for Non-invasive Central Aortic Pressure Monitoring
Authors
James D. Cameron
James E. Sharman
Publication date
06-03-2024
Publisher
Springer Netherlands
Published in
Artery Research
Electronic ISSN: 1876-4401
DOI
https://doi.org/10.1007/s44200-023-00042-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits